Introduction and overview of noninvasive drug monitoring: Preface

Advanced Drug Delivery Reviews

Volumn 41, Issue 1, 2000, Pages 1-5

  Wolf, Walter ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; PLATINUM;

DRUG LABELING; DRUG MONITORING; DRUG RETENTION; DRUG TARGETING; EDITORIAL; IMAGING; PRIORITY JOURNAL; PUBLICATION; SCIENTIFIC LITERATURE;

DIAGNOSTIC IMAGING; DRUG MONITORING; HUMANS;

EID: 0034003184     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(99)00052-6     Document Type: Editorial

References (7)

1. Wolf W. Radiopharmacy. A new profession. Hospitals. 47:1973;18-22.
2. Shani J., Wolf W. A model of prediction of chemotherapy response to 5-FU in sensitive versus resistant lymphocytic leukemia in mice. Cancer Res. 37:1977;2306-2308.
3. 19F NMR. Br. J. Cancer. 50:1984;113-117.
4. Wolf W., Albright M.J., Silver M.S., Weber H., Reichardt U., Sauer R. Fluorine-19 NMR spectroscopic studies of the metabolism of 5-Fluorouracil in the liver of patients undergoing chemotherapy. Magn. Reson. Imag. 5:1987;165-169.
5. 195mPt-cis-diammine-dichloro-platinum. New Developments in Radiopharmaceuticals and Labelled Compounds. Vol. II:1973;205-221 IAEA, Vienna.
6. Wolf W. Imaging can be much more than pretty pictures. Pharm. Sci. 12:1995;1821-1822.
7. Rosenberg B., Van Camp L., Trosko J.E., Mansour V.H. Platinum compounds: a new class of potent antitumor agents. Nature. 222:1969;385-386.